I got diagnosed with immunotherapy-induced T1D last October at the age of 53, as a side effect of Keytruda immunotherapy for synchronous ovarian and uterine cancers. Have been through 3 cancer surgeries, chemotherapy, 2 recurrences, immunotherapy and targeted treatment. Am currently on Libre 3 CGM, Humalog, Lantis, and Arkray brand needles (their lubricated design makes a difference:) and am looking to decrease variability in blood glucose levels. Any wisdom you can share is greatly appreciated… read more
The key to managing blood glucose variability is working closely with your endocrinologist to establish personalized target ranges. While individual needs vary, most people with type 1 diabetes aim to:
• Keep blood glucose between 70-180 mg/dL throughout the day
• Maintain A1C levels below 7%
• Minimize episodes of Show Full Answer